跳至主要内容
临床试验/NCT07207564
NCT07207564招募中不适用

Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 4,500 人开始时间: 2025年8月28日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
4,500
试验地点
2
主要终点
Pathologic features

研究概览

简要总结

The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patients, ages 18 to 100 years
  • Had a benign breast biopsy at Mayo Clinic between 2002-2022

排除标准

  • All male patients
  • Prior or concomitant diagnosis of BC
  • Diagnosis of BC within six months of benign breast disease
  • Denial of research authorization
  • Concurrent or post-biopsy bilateral prophylactic mastectomy

研究组 & 干预措施

Observational

Participants complete a questionnaire, undergo collection of saliva or blood samples, and have their medical records reviewed on study.

干预措施: Non-Interventional Study (Other)

结局指标

主要结局

Pathologic features

时间窗: Baseline (collection of blood or saliva sample)

Will examine pathologic features from benign tissue to define features related to breast cancer (BC) risk.

Radiologic features

时间窗: Baseline (collection of blood or saliva sample)

Will examine radiologic features from mammographic images at time of benign breast disease (BBD) to define features in mammogram images that predict BC risk among women who have a history of BBD. We will also assess whether these features predict BC risk among women without a history of BBD.

Molecular features

时间窗: Baseline (collection of blood or saliva sample)

Will examine molecular features to understand how molecular features, including DNA damage and repair work in the breast tissues of women with BBD and how this might relate to risk of developing BC

Pathologic features

时间窗: Baseline (collection of blood or saliva sample)

Will examine pathologic features from benign tissue to define features related to breast cancer (BC) risk.

Radiologic features

时间窗: Baseline (collection of blood or saliva sample)

Will examine radiologic features from mammographic images at time of benign breast disease (BBD) to define features in mammogram images that predict BC risk among women who have a history of BBD. We will also assess whether these features predict BC risk among women without a history of BBD.

Molecular features

时间窗: Baseline (collection of blood or saliva sample)

Will examine molecular features to understand how molecular features, including DNA damage and repair work in the breast tissues of women with BBD and how this might relate to risk of developing BC

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验